{"entity":{"id":"1979","kind":"year","name":"1979 in oncology","aka":["1979"],"tldr":"Everything OnCo dates to 1979: 9 entries, 3 landmarks, 2 journals founded, 1 approval and 1 company founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.","summary":"9 dated entries in OnCo fall in 1979: 3 landmarks, 2 journals founded, 1 approval, 1 company founded, 1 paper listed on a person's page and 1 technology.\n\nOf those, 9 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.\n\nEverything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.","asOf":"2026-09-25","links":[],"tags":[],"related":["1978","1980"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Generated from every dated field in the corpus, not written by hand. The groups and the fields behind them are listed in src/lib/year-groups.ts; the reader is src/lib/years.ts."],"year":1979,"events":[{"group":"approval","date":"1979","precision":"year","title":"Daunorubicin approved in US","note":"Remission induction in acute non-lymphocytic leukaemia (adults) and acute lymphocytic leukaemia (adults and children), in combination","from":"daunorubicin","refs":[]},{"group":"company","date":"1979","precision":"year","title":"Scandinavian Sarcoma Group founded","note":"Lund","from":"scandinavian-sarcoma-group","refs":[]},{"group":"history","date":"1979","precision":"year","title":"Cisplatin-based therapy cures some 'poorly differentiated carcinoma of unknown primary' (Greco, Hainsworth)","note":"Cancer of unknown primary (CUP). Recognition of the extragonadal germ cell subset.","from":"cancer-of-unknown-primary","refs":[]},{"group":"history","date":"1979","precision":"year","title":"EMA-CO introduced by Bagshawe for high-risk disease","note":"Gestational trophoblastic neoplasia","from":"gestational-trophoblastic","refs":["etoposide","methotrexate","dactinomycin"]},{"group":"history","date":"1979","precision":"year","title":"Rosen's T-10: neoadjuvant chemotherapy and limb salvage","note":"Osteosarcoma","from":"osteosarcoma","refs":["limb-salvage-surgery"]},{"group":"journal","date":"1979","precision":"year","title":"Journal of cancer research and clinical oncology founded","note":"Springer Nature","from":"journal-of-cancer-research-and-clinical-oncology","refs":[]},{"group":"journal","date":"1979","precision":"year","title":"Zhonghua zhong liu za zhi founded","note":"Chinese Medical Association","from":"chinese-journal-of-oncology","refs":[]},{"group":"person-paper","date":"1979","precision":"year","title":"The role of radiation therapy in the treatment of small cell undifferentiated bronchogenic cancer","note":"International Journal of Radiation Oncology*Biology*Physics","from":"ajaikumar-b-s","refs":[]},{"group":"technology","date":"1979","precision":"year","title":"Goldie-Coldman model of resistance","note":"First use in humans or first approval, as the technology record states it.","from":"goldie-coldman-model","refs":[]}]},"route":"/years/1979/","neighbours":{"year":[{"id":"1978","kind":"year","name":"1978 in oncology","route":"/years/1978/"},{"id":"1980","kind":"year","name":"1980 in oncology","route":"/years/1980/"}]}}